Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Apixaban 5 mg vs Eliquis 5 mg in healthy Thai volunteers under fasting
TCTR20230714002Phase 1Unknown
- Sponsor
- Bio-innova
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of apixaban (2 arms), sponsored by Bio-innova. Status: unknown.
02
Drugs
apixaban
Beyond the preview
Go deeper on TCTR20230714002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230714002.